scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Sun Pharma Advanced Research Company Ltd

Feedback
Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Ltd (SPARC) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 1,373,849
Mar 28, 2025 16:01 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹147.91
₹-2.82 (-1.87%)
₹144.73 Low
Today’s Performance
₹152.88 High
₹109.3 Low
52 Week’s Performance
₹472.8 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -1.87%
  • 1 Week 4.32%
  • 1 Month 23.79%
  • 3 Months -25.19%
  • 6 Months -29.05%
  • 1 Year -59.49%
  • 3 Years -19.37%
  • 5 Years 9.65%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 1.00
  • Beta 1.32
  • 52-Week Low (₹) 109.30
  • 52-Week High (₹) 472.80
  • Price-to-Book (X)* 39.23
  • Dividend Yield (%) 0.00
  • Price-to-Earnings (P/E) (X)* -12.70
  • Earnings Per Share (₹) -11.97
  • Sector Price Earning (X)* 34.00
  • Market Cap (₹ Cr.)* 4,891.51
  • * Vaues as of last close price

COMPETITORS

BT TV

Japan Eyes India For Growth: CEOs Meet PM Modi, Talk Trade & Connectivity 1:46 Japan Eyes India For Growth: CEOs Meet PM Modi, Talk Trade & Connectivity
Sectors To Watch In FY26: Mayuresh Joshi On Banking, Healthcare And Rural Growth 2:53 Sectors To Watch In FY26: Mayuresh Joshi On Banking, Healthcare And Rural Growth
FM Nirmala Sitharaman In Rajya Sabha | Explains Timing Of Cuts In Customs Duties 4:50 FM Nirmala Sitharaman In Rajya Sabha | Explains Timing Of Cuts In Customs Duties
Marco Rubio: No U.S. Visas for Students Involved in Campus Chaos and Activism 2:18 Marco Rubio: No U.S. Visas For Students Involved In Campus Chaos And Activism
Chandra Arya Ousted? India Ties Under Fire | Canada’s Liberal Party Faces Backlash Before Elections 2:09 Chandra Arya Ousted? India Ties Under Fire | Canada’s Liberal Party Faces Backlash Before Elections
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE
Sep 19, 2022 Sell
ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 1119999
  • Average Price ₹221.30
Sep 19, 2022 PURCHASE
ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 1119999
  • Average Price ₹221.30
Sep 19, 2022 PURCHASE
ISHARES MSCI INDIA SMALL-CAP ETF
  • Qty 71632
  • Average Price ₹221.30
Sep 19, 2022 Sell
ISHARES INDIA SC MAURITIUS COMPANY
  • Qty 71632
  • Average Price ₹221.30
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Jan 03, 2024 Sell
GRAVITON RESEARCH CAPITAL LLP
  • Qty 2467529
  • Average Price ₹366.63
Jan 03, 2024 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 2467529
  • Average Price ₹366.64
Jan 02, 2024 Sell
GRAVITON RESEARCH CAPITAL LLP
  • Qty 2255109
  • Average Price ₹330.77
Jan 02, 2024 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 2255109
  • Average Price ₹330.65
Aug 30, 2023 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 1994681
  • Average Price ₹251.96
Aug 30, 2023 Sell
GRAVITON RESEARCH CAPITAL LLP
  • Qty 1994681
  • Average Price ₹252.13
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Sun Pharma Advanced Research Company Ltd share price previously?
Sun Pharma Advanced Research Company Ltd share price was down by -1.87% from the previous closing price of ₹150.73.
Who are peers of Sun Pharma Advanced Research Company Ltd?
The peers of Sun Pharma Advanced Research Company Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd,
Who is/are the promoter/promoters of Sun Pharma Advanced Research Company Ltd?
The promotor/promotors of Sun Pharma Advanced Research Company Ltd are T Rajamannar, Sudhir V Valia, Bhavna Doshi, Ferzaan Engineer, Robert Spiegel, Dilip S Shanghvi, Kajal Damania., Vidhi Shanghvi.
What has been 52-week high of Sun Pharma Advanced Research Company Ltd stocks?
The highest price of Sun Pharma Advanced Research Company Ltd stock is ₹472.80 in the last 52-week.
What is the share price of Sun Pharma Advanced Research Company Ltd (SPARC) today on NSE?
As on Mar 28, 2025, Sun Pharma Advanced Research Company Ltd (SPARC)’s share price on NSE is Rs 147.91
What is the market cap of Sun Pharma Advanced Research Company Ltd (SPARC?)
The current market capitalisation of Sun Pharma Advanced Research Company Ltd (SPARC) is 4,891.51 crores
What is Sun Pharma Advanced Research Company Ltd Share symbol?
The symbol of Sun Pharma Advanced Research Company Ltd is SPARC.
What is the PE ratio of Sun Pharma Advanced Research Company Ltd (SPARC)?
The current PE ratio of Sun Pharma Advanced Research Company Ltd (SPARC) is -12.70.
What is the PB ratio of Sun Pharma Advanced Research Company Ltd (SPARC)?
The current PB ratio of Sun Pharma Advanced Research Company Ltd (SPARC) is 39.23.
Today’s High & Low share prices of Sun Pharma Advanced Research Company Ltd (SPARC) on NSE?
Today, the share price of Sun Pharma Advanced Research Company Ltd (SPARC) on NSE touched a high of Rs 152.88 and a low of Rs 144.73
What price did Sun Pharma Advanced Research Company Ltd (SPARC) shares open on the NSE today?
On NSE, the share price of Sun Pharma Advanced Research Company Ltd (SPARC) opened at Rs 151.5
What is the 52-week high of Sun Pharma Advanced Research Company Ltd (SPARC)?
The 52-week high price of Sun Pharma Advanced Research Company Ltd (SPARC) is Rs 472.8
What is the 52-week low of Sun Pharma Advanced Research Company Ltd (SPARC) ?
The 52-week low price of Sun Pharma Advanced Research Company Ltd (SPARC) is Rs 109.3

ABOUT SPARC

Sun Pharma Advanced Research Company Ltd, incorporated in the year 2006, has its registered office in Sun Pharma Advanced Res Centre, Akota Road Akota, Vadodara, Gujarat, 390020, 91-265-2330815/2339257, 91-265-2354897. The main industry in which Sun Pharma Advanced Research Company Ltd operates is Miscellaneous.

Auditor/Auditors for Sun Pharma Advanced Research Company Ltd is/are S R B C & Co LLP. In the main management, Dilip S Shanghvi is chairman and Kajal Damania. is the company secretary for Sun Pharma Advanced Research Company Ltd.

  • TR T Rajamannar Non Executive Director
  • SVV Sudhir V Valia Non Executive Director
  • BD Bhavna Doshi Independent Director
  • FE Ferzaan Engineer Independent Director
  • RS Robert Spiegel Independent Director
  • DSS Dilip S Shanghvi Chairman (Non-Executive)
  • KD Kajal Damania. Company Sec. & Compli. Officer
  • VS Vidhi Shanghvi Non Executive Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement